Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 50 Key Players companies in Levodopa
by Most Patent Filings in the United States in 2021

The Levodopa top 50 is Discovery PatSnap’ annual ranking of the top 50 Most Patent Filings Levodopa Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
Health care,Biopharmaceutical,Drug,
...[+2]
Patent: 108
2
Levodopa,Biology,Pharmacy and Therapeutics,
...[+2]
Patent: 106
3
Health care,Medicine,Biopharmaceutical,
...[+2]
Patent: 72
4
Patent: 69
5
Patent: 64
6
Medicine,Health care,Central nervous system,
...[+2]
Patent: 37
7
Patent: 34
8
Patent: 20
9
Patent: 20
10
Trade partner,Corporate social responsibility,Medicine,
...[+2]
Patent: 14
11
Medicine,Health care,Microdialysis,
...[+2]
Patent: 14
12
Health care,Pharmacy and Therapeutics,Medical product,
...[+2]
Patent: 12
13
Drug,Health care,Route of administration,
...[+2]
Patent: 12
14
Health care,Curcumin,Feed additive,
...[+2]
Patent: 11
15
Health care,Clinical trial,Drug,
...[+2]
Patent: 10
16
Drug molecule,Health care,Medicine,
...[+2]
Patent: 10
17
Endometriosis,Medicine,Health care,
...[+2]
Patent: 9
18
Patent: 9
19
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Patent: 9
20
Green chemistry,Chemical engineering,Sustainable design,
...[+1]
Patent: 9
21
Patent: 9
22
Patent: 9
23
Patent: 8
24
Medicine,Cardiovascular agent,Clinical trial,
...[+2]
Patent: 7
25
Patent: 7
26
Patent: 7
27
Patent: 6
28
Andaman Therapeutics, Inc.
Health care
Patent: 6
29
Market potential,Medicine,Health care,
...[+2]
Patent: 5
30
Premature ejaculation,Medicine,Apomorphine,
...[+2]
Patent: 5
31
Patent: 5
32
Medicine,Pharmacy and Therapeutics,Inhalation,
...[+2]
Patent: 4
33
Medicine,Health care,Biotechnology,
...[+2]
Patent: 4
34
Patent: 4
35
Patent: 4
36
Patent: 4
37
Chromatography,Fast-moving consumer goods,Protein A,
...[+2]
Patent: 3
38
Opioid,Medicine,Opioid epidemic,
...[+2]
Patent: 3
39
Health care,Healthcare system,Educational program,
...[+1]
Patent: 3
40
Working capital,Pathology,Companion diagnostic,
...[+2]
Patent: 3
41
Patent: 3
42
Patent: 3
43
Patent: 3
44
Medicine,Health care,Cardiovascular agent,
...[+2]
Patent: 2
45
Medicine,Pharmacy and Therapeutics,Multiple sclerosis,
...[+2]
Patent: 2
46
Biology,Medicine,Health care,
...[+2]
Patent: 2
47
Health care,Repaglinide,Risedronate Sodium,
...[+2]
Patent: 2
48
Patent: 2
49
Medicine,Pharmacy and Therapeutics,Typical antipsychotic,
...[+2]
Patent: 2
50
Patent: 2
Page generation time: May 14 2025